GIST Alliance: Find a Glivec Blood Level Testing Lab for Your Patients
GIST ALLIANCE provides easy access to GLIVEC blood level testing
Glivec blood level testing will help identify patients that may have a lower probability of achieving an optimal outcome.
GLIVEC plasma trough levels above 1100 ng/mL have been shown to correlate with significantly better clinical outcomes1,2
Blood level testing for patients with GIST may help optimize clinical benefit from GLIVEC1,2
North America
Europe
Asia
Australia
USA www.gistalliance.com
Europe click here
China click here
Australia www.gistalliance.com.au
Canada click here
Middle East & Africa
Hong Kong click here
South America
Jordan click here
Thailand click here
Argentina click here
Isreal click here
Singapore click here
South Africa click here
Taiwan click here
Turkey click here
South Korea click here
References:
1.
Demetri GD, Wang Y, Wehrle E, Blanke C, Joensuu H, von Mehren M. Correlation of imatinib plasma levels with clinical benefit in patients (Pts) with unresectable/metastatic gastrointestinal stromal tumors (GIST). Presented at: ASCO Gastrointestinal Cancers Symposium; January 25-27, 2008; Orlando, FL. Abstract 3 and Slides.
2.
von Mehren M, Wang Y, Joensuu H, Blanke CD, Wehrle E, Demetri GD. Imatinib pharmacokinetics (PK) and its correlation with clinical response in patients with unresectable/metastatic gastrointestinal stromal tumor (GIST). J Clin Oncol. 2008;26(suppl):Abstract 4523.
Disclaimer: This is an international website dedicated to GIST, and intended for healthcare professionals outside the US. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.
Home | Glivec Blood Level Testing | Find a Blood Level Testing Lab | About Novartis Oncology | Tell a Colleague
Contact | Site Map | Terms of Use | Privacy Policy